These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Innervation of the airways in asthma bronchiale and chronic obstructive pulmonary disease (COPD)]. Dinh QT; Suhling H; Fischer A; Braun A; Welte T Pneumologie; 2011 May; 65(5):283-92. PubMed ID: 21271508 [TBL] [Abstract][Full Text] [Related]
49. [Peptidergic and sensory mechanisms, parasympathetic and sympathetic nerves]. Lundberg JM; Lundblad L; Martling CR; Anggård A Lakartidningen; 1984 Dec; 81(52):4939-42. PubMed ID: 6098795 [No Abstract] [Full Text] [Related]
50. New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy. Mandlik DS; Mandlik SK Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):521-544. PubMed ID: 32938247 [TBL] [Abstract][Full Text] [Related]
51. Anticholinergic therapy for airway diseases. Jacoby DB; Fryer AD Life Sci; 2001 Apr; 68(22-23):2565-72. PubMed ID: 11392627 [TBL] [Abstract][Full Text] [Related]
52. Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung. Fryer AD; Adamko DJ; Yost BL; Jacoby DB Life Sci; 1999; 64(6-7):449-55. PubMed ID: 10069509 [TBL] [Abstract][Full Text] [Related]
53. Control of airway caliber by autonomic nerves in asthma and in chronic obstructive pulmonary disease. de Jongste JC; Jongejan RC; Kerrebijn KF Am Rev Respir Dis; 1991 Jun; 143(6):1421-6. PubMed ID: 2048831 [TBL] [Abstract][Full Text] [Related]
54. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Kistemaker LE; Oenema TA; Meurs H; Gosens R Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302 [TBL] [Abstract][Full Text] [Related]
55. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target. Meurs H; Dekkers BG; Maarsingh H; Halayko AJ; Zaagsma J; Gosens R Pulm Pharmacol Ther; 2013 Feb; 26(1):145-55. PubMed ID: 22842340 [TBL] [Abstract][Full Text] [Related]
56. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899 [TBL] [Abstract][Full Text] [Related]